{
  "id": 5468,
  "text": "Int J Radiat Oncol Biol Phys 2007;67:1438- 1444.Available at: http://www.ncbi.nlm.nih.gov/pubmed/17394944.286.Chen M-F, Tseng C-J, Tseng C-C, et al.Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Int J Radiat Oncol Biol Phys 2007;67:1438- 1444.Available at: http://www.ncbi.nlm.nih.gov/pubmed/17394944.286.Chen M-F, Tseng C-J, Tseng C-C, et al.Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "选择在早期高风险宫颈癌患者手术后进行伴随放化疗的调强盆腔放射治疗主要是因为这一治疗方案能有效降低癌症复发的风险，提高患者的生存率。调强放射治疗（IMRT）能够准确定位和照射盆腔区域的高风险病变组织，同时减少对周围正常组织的损伤。结合化疗一起使用可以增强放射治疗的效果，通过增加癌细胞对辐射的敏感性，提高整体治疗效果。这种综合疗法适用于那些手术后存在高复发风险的患者，如淋巴结阳性、肿瘤浸润深度较大或手术边缘不清的情况，从而提供全面的术后保护。",
  "query": "在早期高风险宫颈癌患者手术后，为什么选择进行伴随放化疗的调强盆腔放射治疗？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在早期高风险宫颈癌患者手术后，为什么选择进行伴随放化疗的调强盆腔放射治疗？\n\n<reference text>: Int J Radiat Oncol Biol Phys 2007;67:1438- 1444.Available at: http://www.ncbi.nlm.nih.gov/pubmed/17394944.286.Chen M-F, Tseng C-J, Tseng C-C, et al.Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "选择在早期高风险宫颈癌患者手术后进行伴随放化疗的调强盆腔放射治疗主要是因为这一治疗方案能有效降低癌症复发的风险，提高患者的生存率。调强放射治疗（IMRT）能够准确定位和照射盆腔区域的高风险病变组织，同时减少对周围正常组织的损伤。结合化疗一起使用可以增强放射治疗的效果，通过增加癌细胞对辐射的敏感性，提高整体治疗效果。这种综合疗法适用于那些手术后存在高复发风险的患者，如淋巴结阳性、肿瘤浸润深度较大或手术边缘不清的情况，从而提供全面的术后保护。"
}